Literature DB >> 19237649

Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Klaudia Kosowska-Shick1, Pamela McGhee, Peter C Appelbaum.   

Abstract

Faropenem demonstrated low MICs (< or = 1 microg/ml) for all penicillin-susceptible and nonsusceptible pneumococci and exhibited very strong abilities to bind to Streptococcus pneumoniae penicillin-binding proteins (PBPs), except for PBP2X. The lower faropenem affinity for PBP2X did not affect MICs for any strains tested, and only imipenem had lower MICs, with much lower binding affinities for all PBPs tested, than faropenem.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237649      PMCID: PMC2681536          DOI: 10.1128/AAC.01566-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae.

Authors:  R Muñoz; C G Dowson; M Daniels; T J Coffey; C Martin; R Hakenbeck; B G Spratt
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

Review 2.  Resistance to antibiotics mediated by target alterations.

Authors:  B G Spratt
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.

Authors:  Kensuke Nagai; Todd A Davies; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.

Authors:  K Kosowska; M R Jacobs; S Bajaksouzian; L Koeth; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site.

Authors:  R Hakenbeck; H Ellerbrok; T Briese; S Handwerger; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.

Authors:  R Hakenbeck; S Tornette; N F Adkinson
Journal:  J Gen Microbiol       Date:  1987-03

8.  Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  G Laible; B G Spratt; R Hakenbeck
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

9.  Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.

Authors:  T Grebe; R Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.

Authors:  A Dalhoff; T Nasu; K Okamoto
Journal:  Chemotherapy       Date:  2003-07       Impact factor: 2.544

View more
  7 in total

1.  Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.

Authors:  Ozden Kocaoglu; Ho-Ching T Tsui; Malcolm E Winkler; Erin E Carlson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.

Authors:  Robert K Flamm; Helio S Sader; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

3.  Molecular analysis of pbp2b in Streptococcus pneumonia isolated from clinical and normal flora samples.

Authors:  J Sadeghi; A Ahamadi; M Douraghi; M R Pourshafie; M Talebi
Journal:  Curr Microbiol       Date:  2014-10-02       Impact factor: 2.188

4.  Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.

Authors:  K Kosowska-Shick; P L McGhee; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 5.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

6.  Long Persistence of a Streptococcus pneumoniae 23F Clone in a Cystic Fibrosis Patient.

Authors:  Martin Rieger; Harald Mauch; Regine Hakenbeck
Journal:  mSphere       Date:  2017-06-07       Impact factor: 4.389

Review 7.  Mechanisms of action and antimicrobial activity of ceftobiprole.

Authors:  M I Morosini; M Díez-Aguilar; R Cantón
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.